Detalhe da pesquisa
1.
Hypereosinophilic syndrome in Europe: Retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization.
Ann Allergy Asthma Immunol
; 130(6): 768-775, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863663
2.
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172466
3.
Inadequate housing and pulmonary tuberculosis: a systematic review.
BMC Public Health
; 22(1): 622, 2022 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354400
4.
Characteristics and treatment regimens across ERS SHARP severe asthma registries.
Eur Respir J
; 55(1)2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601713
5.
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
Respir Res
; 20(1): 169, 2019 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362741
6.
Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
Am J Respir Crit Care Med
; 194(5): 568-76, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27442601
7.
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
Respir Res
; 17(1): 157, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881132
8.
Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma.
Clin Exp Allergy
; 50(7): 869-872, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515118
9.
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma.
Allergy
; 75(8): 2085-2088, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147844
10.
The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: An observational survey.
Respirology
; 20(4): 602-11, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25781616
11.
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics.
ERJ Open Res
; 10(1)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196889
12.
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.
Eur Respir J
; 52(5)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30498052
13.
HES and EGPA: Two Sides of the Same Coin.
Mayo Clin Proc
; 98(7): 1054-1070, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419574
14.
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome.
Front Med (Lausanne)
; 10: 1035250, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064032
15.
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.
ACR Open Rheumatol
; 5(7): 354-363, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312233
16.
What bothers severe asthma patients most? A paired patient-clinician study across seven European countries.
ERJ Open Res
; 9(3)2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260457
17.
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
ERJ Open Res
; 9(2)2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020841
18.
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome.
Front Immunol
; 13: 840974, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35493455
19.
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases.
J Patient Exp
; 9: 23743735221143953, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36530646
20.
Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome.
Front Immunol
; 13: 935996, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091012